Key highlights of the journal publications are:
The editorial by Dr. Yogita S. Karandikar delves into India’s pivotal role in biosimilar development, highlighting its early adoption and substantial market impact. It underscores India’s potential as a global leader in providing affordable healthcare solutions through biosimilars, backed by robust research and manufacturing capabilities. Dr. Karandikar’s editorial also discusses the cost-saving benefits of biosimilars, particularly in the Indian market, and the regulatory framework governing their approval. It concludes by emphasizing the importance of biosimilars in expanding patient access to effective treatments amidst rising healthcare costs and chronic disease prevalence.
- Clinicoepidemiological Features of Hand Eczema in Healthcare Workers during COVID 19 Pandemic
- Assessment of the Fetal Diastolic Component of the Cardiac Cycle with Spectral Doppler E/A Ratio Through the Atrioventricular Valves in Normal Fetuses and Intrauterine Growth-restricted Fetuses
- A Case of Persistent Hypokalemia
- A Rare Case of Unilateral Ovarian Sex Cord Tumor with Annular Tubules
- Acroangiodermatitis of Mali: A Rare Case Report
MJBAR has been proposed to EBSCO, IndexCopernicus, Embase, Scopus and ProQuest.
Manuscripts can be submitted to MJBAR by:
1. Online submission using the ‘Online Submission’ page of the MJBAR website viewed at: mediaedgemarketing.com (preferred medium)
OR
2. As an email with attached files (Cover Letter, Manuscript File, Copyright transfer/ Financial Disclosure/Conflict of Interest and Authorship Contributions and Submission Form) to: journal@mediaedgemarketing.com (In case of technical issue).